Testosterone replacement therapy such as AndroGel and Axiron has been linked to a 63 percent increased risk of serious blood clots in the first six months of use, according to a new study published in the British Medical Journal. Blood clots associated with testosterone treatments form in the veins, a condition known as venous thromboembolism (VTE). These clots are the kind that can cause deep vein thrombosis, pulmonary embolism (blood clots in the lungs), leading to heart attacks, strokes, organ damage or death, according to the American Heart Association. “Risk peaks rapidly in the first six months of treatment and ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.